|
Market Closed -
NSE India S.E.
04:35:08 13/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,884.00 INR | -0.83% |
|
-2.98% | +32.78% |
| 06/11 | Ipca Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
| 05/11 | Ipca Laboratories Limited, Q2 2027 Earnings Call, Nov 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 506.93Cr | |||||
| 1,28600Cr | |||||
| 69TCr | |||||
| 52TCr | |||||
| 39TCr | |||||
| 36TCr |
Select your edition
All financial news and data tailored to specific country editions
